Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics - Deniau, Benjamin; Rehfeld, Linda; Santos, Karine; Dienelt, Anke; Azibani, Feriel; Sadoune, Malha; Kounde, Paul R.; Samuel, Jane L.; Tolpannen, Heli; Lassus, Johan; Harjola, Veli‐Pekka; Vodovar, Nicolas; et al. (European journal of heart failure, 2020)
Keywords: Acute heart failure; Animals; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized - therapeutic use; Antibody; Biomarkers; cDPP3; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - antagonists & inhibitors; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - blood; Heart Failure - drug therapy; Heart Failure - mortality; Hemodynamics - drug effects; Humans; Immunotherapy; Life Sciences; Mice; Procizumab; Biomarkers; cDPP3; Procizumab; Antibody; Immunotherapy; Acute heart failure